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Background: At present, phenotypic growth inhibition techniques are used in routine
diagnostic microbiology to determine antimicrobial resistance of bacteria. Molecular
techniques such as PCR are often used for confirmation but are indirect as they detect
particular resistance genes. A direct technique would be able to detect the proteins
of the resistance mechanism itself. In the present study targeted high resolution mass
spectrometry assay was developed for the simultaneous detection of KPC, OXA-48-like,
NDM, and VIM carbapenemases.
Methods: Carbapenemase specific target peptides were defined by comparing
available sequences in GenBank. Selected peptide sequences were validated using 62
Klebsiella pneumoniae and Escherichia coli isolates containing: 16 KPC, 21 OXA-48-
like, 16 NDM, 13 VIM genes, and 21 carbapenemase negative isolates.
Results: For each carbapenemase, two candidate peptides were validated. Method
validation was performed in a blinded manner for all 83 isolates. All carbapenemases
were detected. The majority was detected by both target peptides. All target peptides
were 100% specific in the tested isolates and no peptide carry-over was detected.
Conclusion: The applied targeted bottom-up mass spectrometry technique is able to
accurately detect the four most prevalent carbapenemases in a single analysis.
Keywords: carbapenemases, Eschericha coli, Klebsiella pneumoniae, mass spectrometry – LC-MS/MS, parallel
reaction monitoring, antimicrobial resistance
INTRODUCTION
The continuous increase of antimicrobial resistance in a diverse group of microorganisms is a major
threat in the 21st century (WHO, 2014). Among several resistance mechanisms, carbapenemases
are of particular concern. They not only hydrolyze carbapenem antibiotics, one of our last resort
antibiotics, but the carbapenemases KPC, NDM, and VIM also hydrolyze cephalosporins with
expanded-spectrum activity. Presence of additional resistance mechanisms results in multidrug
resistance. Consequently, the treatment options for infections caused by carbapenemase-producing
Enterobacterales (CPE) are limited (Stewart et al., 2018; Tacconelli et al., 2018).
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To facilitate early adequate therapy for patients infected by
CPE or other multidrug resistant bacteria, there is a need for new
precise and rapid diagnostic methods (O’Neill, 2016). Shorter
turnaround times for antimicrobial resistance determination
leads to earlier appropriate antibiotic therapy and can contribute
to a decrease in morbidity, mortality, length and cost of hospital
stay, and can improve antibiotic stewardship (Kerremans et al.,
2008; Perez et al., 2014; Pliakos et al., 2018).
In general, resistance determinations are performed by
phenotypic growth inhibition assays which delay the time
to result (van Belkum and Dunne, 2013; Zhou et al., 2018).
Besides unfavorable turnaround time, phenotypic techniques
are not optimal for detection of the different carbapenemase
enzymes. This is especially the case for OXA-48-like enzymes
with weak hydrolytic activity, often resulting in MIC’s below
the “S”-breakpoint for carbapenems (Tamma and Simner,
2018). Furthermore, growth inhibition assays cannot classify
the different carbapenemase enzymes. Classification of
carbapenemases is crucial as new antibiotic combinations
such as ceftazidime/avibactam can be effective against species
producing KPC and OXA-48 but not against those producing
NDM or VIM (Hawkey et al., 2018).
The presence of carbapenemases is generally confirmed by
tests such as the Carbapenem Inactivation Method (CIM)
or Carba NP (Meier and Hamprecht, 2019). These assays
demonstrate carbapenemase activity but do not specify which
carbapenemase is present.
PCR is also used for detection of carbapenemases. Although
this technique has many benefits it does not provide information
on the actual expression of the particular proteins (Traczewski
et al., 2018; Schmidt et al., 2019). In contrast, lateral flow
immunoassays do detect specific proteins rapidly and a recently
marketed assay is able to detect the five main carbapenemases,
i.e., KPC, OXA-48-like, NDM, VIM, and IMP with high
sensitivity and specificity (Boutal et al., 2018).
New MS based methods could be an alternative to PCR
and immunoassays (Charretier and Schrenzel, 2016; Oviano and
Bou, 2019). In the last few years, several methods have been
identified which detect carbapenemases indirectly by measuring
hydrolysis of carbapenems using MALDI-TOF (Oviano and Bou,
2019). In contrast, direct and specific detection of prevalent
carbapenemases such as KPC, NDM, OXA-48-like, and VIM
by MALDI-TOF has not been demonstrated (Charretier and
Schrenzel, 2016; Oviano and Bou, 2019). The MALDI-TOF
which is currently used in clinical microbiology laboratories was
designed to create a spectral fingerprint of abundant proteins.
Therefore, its ability to directly detect low abundant proteins in
complex samples is limited (Charretier and Schrenzel, 2016).
However, by combining high resolution mass spectrometry
with liquid chromatography (LC) specific resistance
mechanisms can be detected (Charretier and Schrenzel,
2016). Chromatographic separation and the use of a quadrupole
to select for mass to charge ratios of target peptides can increase
sensitivity, specificity and reproducibility of peptide detection
(Charretier and Schrenzel, 2016; Banaei-Esfahani et al., 2017).
Measurements can thereafter take place by selected reaction
monitoring (SRM) in which selected fragments of selected
peptides are measured; or parallel reaction monitoring (PRM)
in which all peptide fragments of selected peptides are measured
simultaneously, further increasing the selectivity of the assay
(Guzel et al., 2018). High resolution targeted LC-MS/MS, either
based on SRM or PRM could have potential for future resistance
testing. By rapidly detecting specific peptides of many prevalent
resistance mechanisms in a single assay, resistance to several
representative antibiotics could be predicted for frequently
isolated pathogens. So far, several studies have demonstrated
direct detection of different resistance mechanisms using these
targeted approaches (Charretier et al., 2015; Charretier and
Schrenzel, 2016; Hassing et al., 2016). Furthermore, detection
by high-resolution MS of each carbapenemase separately i.e.,
KPC (Wang et al., 2017), NDM (Cecchini et al., 2018), and
OXA-48-like (Strich et al., 2019) has been demonstrated in
different studies. However, in the present proof of concept
study the aim was to apply LC-MS/MS for simultaneous
detection of the prevalent key carbapenemases KPC, OXA-
48-like, NDM, and VIM in cultures of Escherichia coli and
Klebsiella pneumoniae.
MATERIALS AND METHODS
Bacterial Isolates and PCR
In the present study, 83 strains were analyzed. Ethical approval
was not required, as only stored bacterial isolates were used.
The selected bacteria were: 63 K. pneumoniae consisting
of 16 K. pneumoniae carbapenemase (KPC) positives, 17
oxacillinase-48-like (OXA-48-like) positives, 11 New Delhi
metallo-β-lactamase (NDM) positives, 13 Verona integron-
encoded metallo-β-lactamase (VIM) positives, and 10
carbapenem susceptible isolates; 20 E. coli consisting of 4
OXA-48-like positives, 5 NDM positives and 11 carbapenem-
susceptible isolates. Of these, 2 KPC positive, 1 OXA-48-like
positive, 2 NDM positive, 2 VIM positive, and 5 carbapenemase
negative isolates were initially used for method development.
Isolates were either obtained from the Erasmus MC collection
or from the National Institute for Public Health and the
Environment. VIM-positive K. pneumoniae isolates were
obtained from the National School of Public Health, Athens,
Greece. All strains were previously identified in our laboratory
using the MALDI biotyper (Bruker, Billerica, MA, United States).
Presence of KPC, OXA-48-like, NDM, and VIM enzymes was
confirmed using in-house real-time PCR. The primers and probes
that were used for PCR are listed in Supplementary Table 1.
Peptide Selection
A BLASTn search was performed on the non-redundant
GenBank database to find all available variants of blaKPC,
blaNDM , blaVIM , and blaOXA−48−like. This included all curated
subtypes (GenBank accession number PRJNA313047) as well
as additional unique non-curated variants that were assigned
a subtype and unannotated variants. Only full length or
near full length hits were included. DNA sequences were
translated into proteins and these were aligned using ClustalX
(Larkin et al., 2007). Proteins were digested in silico with
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trypsin to identify tryptic candidate peptides for targeted
MS. Peptides of 6–20 amino acids were selected based on
maximum coverage of subtypes. Specificity of peptides in
Enterobacterales was assessed using BLASTp. To select a suitable
internal control peptide, 900 K. pneumoniae and E. coli
reference genomes were randomly selected from GenBank.
Sequences were subsequently annotated with Prokka v1.13
and translated into proteins (Seemann, 2014). Ribosomal
protein S1 was present in all genomes. From this protein, a
conserved peptide of suitable length was selected which was
identical in all strains.
Culture Protocol
Isolates stored at −80◦C were subcultured on TrypticaseTM
Soy Agar II plates with 5% sheep blood (Becton Dickinson,
Franklin Lakes, NJ, United States) and incubated overnight
at 37◦C. Subsequently, one inoculation loop with bacteria
was inoculated in Mueller Hinton II broth and cultured
overnight at 37◦C and 150 rpm. Resulting broth was diluted
with Mueller Hinton II broth until absorbance of 0.98–1.02
at 600 nm wavelength was reached. Subsequently, 1 ml was
centrifuged for 5 min at 21,000 × g. The resulting pellet was
washed once with 500 µl phosphate-buffered saline and stored
at−20◦C.
Lysis and Digestion Protocol
A schematic overview of the lysis and digestion protocol is
shown in Figure 1. Bacterial pellets were dissolved in 100 µl
lysis solution containing 5% sodium deoxycholate and 7.5 mM
dithiothreitol in water. Ten microliter of stable isotope-labeled
(SIL) peptide solution was added containing 5 pmol labeled
OXA-48-like and NDM peptides, 1 pmol KPC peptides and
0.5 pmol VIM peptides. SIL variant peptides were obtained
of selected target peptides via Pepscan, Lelystad, Netherlands.
Concentrations of SIL peptides were optimized in a pilot
experiment to obtain ratios to target peptides close to one.
Samples were sonicated for 5 min (Branson 2510 Ultrasonic
Cleaner, Branson Ultrasonics, Danbury, United States) and
incubated for 10 min at 80◦C, 450 rpm in a heater-shaker
(Eppendorf ThermoMixer R© C, Eppendorf, Hamburg, Germany).
One and a half microliter of 500 mM dithiothreitol was
added and samples were incubated for 20 min at 60◦C
and 450 rpm. Subsequently, 7 µl 375 mM iodoacetamide
was added followed by 30 min of incubation in the dark
at room temperature. Samples were diluted 10-fold using
MS grade water, 1 µl trypsin (1 µg/µl) (Worthington,
NJ, United States) was added followed by 25 µl Tris–
HCl buffer (pH 8). In general, samples were incubated
overnight, however, different trypsin incubation periods of
1, 2, and 4 h were tested in separate experiments (37◦C,
450 rpm). After trypsinization, 20 µl 5% trifluoroacetic acid
was added followed by 30 min of incubation at 37◦C and
450 rpm. Digests were centrifuged for 60 min at 4◦C,
21,000 × g and 500 µl of supernatant was stored at 5◦C
awaiting LC-MS/MS.
LC-MS/MS
Digests were loaded onto Evotips (Evosep, Odense, Denmark)
according to the manufacturer’s instructions (Bache et al., 2018).
Evotips were soaked in isopropanol and sequentially washed
with 20 µl acetonitrile with 0.1% formic acid, equilibrated
with 20 µl water with 0.1% formic acid (solvent A), loaded
with 20 µl sample, washed with 20 µl solvent A and
loaded with 100 µl solvent A. Tips were centrifuged for
60 s at 700 × g between each loading step. The Evotips
were submerged in 0.1% formic acid on a 96-wells plate
during sample loading to prevent drying. After the last
step, tips were centrifuged for 20 s at 700 × g. LC was
performed by the Evosep One (Evosep, Odense, Denmark)
using the manufactures separation method of 11.5 min (100
samples/day) (Bache et al., 2018). The Evosep One was
coupled to an Orbitrap mass spectrometer (Q Exactive HF
Hybrid Quadrupole-Orbitrap, Thermo Fisher Scientific, Bremen,
Germany). The Q Exactive HF system was operated in
PRM mode using the following parameters: a quadrupole
isolation window of 0.6 m/z units, an automatic gain control
target value of 1 × 106 ions, a maximum fill time of
150 ms and a resolving power of 60,000 at 200 m/z.
A normalized collision energy of 27% was used for all
peptides. A retention time window of 2 min was used
for each peptide.
Data Analysis
Raw data was loaded and analyzed using Skyline (Skyline 3.7
or later, MacCoss Lab Software, University of Washington,
United States). Spectral peak areas of target peptides were
calculated by summing up fragment peak areas. For each target
the ratio between the peak area of the endogenous peptide and
of the SIL peptide was calculated. A peptide was considered
present when the following criteria were met: Retention time
similar to that of the SIL peptide, presence of all fragments,
ratio dot products (rdotp) >0.95 and mass error <5 ppm. The
rdotp is a measure of similarity between the fragment ratio of
the endogenous and SIL peptide (Strich et al., 2019). Results
were compared with PCR for all samples. Sensitivity, specificity
and their respective 95% CI were calculated using VassarStats:
FIGURE 1 | Schematic overview of the LC-MS/MS pre-treatment used in this study.
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Website for Statistical Computation1. Coefficients of variation
(CV) were calculated using Microsoft Excel.
RESULTS
Detection of Candidate Peptides
From the protein analysis of the four target genes i.e.,
KPC, OXA-48-like, NDM, and VIM, several peptides were
selected in silico as target peptides to be used as markers
for presence of the aforementioned carbapenemases. All
candidate peptides are displayed in Supplementary Table 2.
Suitability of candidate peptides was tested on a selected
panel of 12 isolates containing all four carbapenemase
genes. The aim was to select two suitable peptides for
each carbapenemase. For the detection of the KPC-
carbapenemase, four candidate peptides were tested. The
peptides GFLAAAVLAR and APIVLAVYTR were detected
in both KPC-positive samples, however, peak areas were
extremely variable making them less suitable as reliable markers.
Peptides SIGDTTFR and FPLCSSFK were also detected in
both samples and peak areas were similar. Therefore, these
were selected for further validation. In the detection of
the OXA-48-like and NDM carbapenemases the first two
peptides were tested, all four showed good results so no
other candidates were tested. In the detection of the VIM-
carbapenemase, candidate peptides DGDELLLIDTAWGAK,
VGGVDVLR, and NTAALLAEIEK were tested. As the
latter two showed higher peak areas they were selected for
further validation. The peptide selected as internal control
HEAWITLEK was detected in all 12 samples. The final
peptide panel used for validation consisted of the eight
selected carbapenemase peptides and the internal control
peptide (Table 1). To assess possible sample carry-over, several
negative samples were analyzed preceded by known positive
samples. No carry-over was detected for any of the selected
peptides (e.g., Figure 2).
Specificity Assessment Using BLASTp
Specificity of the selected KPC, OXA-48-like, NDM,
and VIM peptides was assessed by performing BLASTp
searches for the peptides in Enterobacterales. Results
showed the KPC peptide SIGDTTFR was also present
in the class A carbapenemase SED found in Citrobacter
isolates. The other peptide selected for KPC detection, i.e.,
FPLCSSFK was also present in the low prevalent class A
carbapenemases FRI, SME, IMI, and NMC found in various
Enterobacterales. None of the peptides selected for detection
of OXA-48-like, NDM, and VIM enzymes were present in
any other protein.
Reproducibility Assessment
To assess the robustness of the method, reproducibility
was tested using two strains positive for both OXA-48-
like and NDM carbapenemases and two strains positive
1http://vassarstats.net TA
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FIGURE 2 | LC-MS/MS chromatograms of the OXA-48-like peptide ANQAFLPASTFK in Skyline for an OXA-48-like positive sample (A) and an OXA-48-like negative
sample (B). The negative sample was measured right after the strong positive sample and no carry-over of the target peptide was detected. Intensity of fragments in
unadjusted units (multiplied by 106 for the positive sample and 103 for negative sample) is plotted against retention time in minutes.
for both KPC and VIM. Five ml cultured broth of each
strain was distributed over five aliquots and processed
separately. CV’s of endogenous to SIL peptide ratios were
determined for all peptides (Table 2). Mean CV’s were
15.2% for SIGDTTFR (KPC), 22.5% for FPLCSSFK (KPC),
9.4% for ANQAFLPASTFK (OXA-48-like), 10.7% for
SWNAHFTEHK (OXA-48-like), 54.2% for FGDLVFR (NDM),
9.4% for VGGVDVLR (VIM), and 13.2% for NTAALLAEIEK
(VIM). The CV of QEINLPVALAVVTHAHQDK was
not determined as the peptide was false negative in both
NDM-positive samples.
Method Validation
After in silico and experimental selection of the eight target
peptides and reproducibility assessment, the method was
validated using all 83 previously characterized isolates in a
blinded manner. All carbapenemase enzymes were detected
by the assay (Table 3). However, not all selected peptides
were 100% sensitive. The VIM-peptide NTAALLAEIEK did
miss one out of 13 VIM positive K. pneumoniae isolates
(sensitivity 92%, 95% CI, 62–100%). Furthermore, the NDM-
peptide QEINLPVALAVVTHAHQDK (NDM) was detected in
only 4 out of 16 isolates resulting in a sensitivity of 25%
(95% CI, 8–53%). All other peptides were 100% sensitive. All
peptides were 100% specific and no carry-over was detected.
Interference of background signal did not lead to false positive
results as there were no interfering peaks which met the
detection criteria. The internal control peptide of the 30 S
ribosomal protein S1 was present in all samples except for
one VIM positive K. pneumoniae isolate. To optimize the
accuracy of peptide detection, SIL variants of each target
peptide were added during the extraction procedure. Ratios
of endogenous to SIL peptides are depicted in Figure 3 for
all 83 isolates. It was observed that the ratios for individual
peptides covered a dynamic range of nearly three orders of
magnitude. Even for the samples with the lowest abundance of
target peptides, a clear signal which passed all detection criteria
was still observed.
Assessment of Protocol With Shorter
Digestion Times
For the validation set, samples were incubated overnight for
trypsin digestion. To assess whether shorter trypsin digestion
times would compromise sensitivity, two strains positive
for both OXA-48-like and NDM carbapenemases and two
strains positive for both KPC and VIM were cultured in
broth and four ml of each strain was distributed over four
aliquots. Each was incubated with trypsin, either for 1, 2,
4 or 16 h. NTAALLAEIEK (VIM), VGGVDVLR (VIM),
SIGDTTFR (KPC), FGDLVFR (NDM), SWNAHFTEHK
(OXA-48-like), and ANQAFLPASTFK (OXA-48-like) were
all positive according to our detection criteria in the
four samples digested for 1 h, albeit with lower ratios to
reference peptides. Optimal detection of FPLCSSFK (KPC)
required at least 2 h before all detection criteria were met
and QEINLPVALAVVTHAHQDK (NDM) even required
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TABLE 2 | Intensity ratios and coefficients of variation (CV) of the eight target peptides using two strains positive for both OXA-48-like and NDM and two strains positive
for both KPC and VIM.
Carbapenemase Target peptide Range of intensity
ratios first sample
CV first sample
(%)
Range of intensity
ratios second sample
CV second
sample (%)
KPC SIGDTTFR 0.60–0.79 11.5 0.50–0.78 18.9
FPLCSSFK 0.67–1.40 28.5 0.62–0.95 16.5
OXA-48-like ANQAFLPASTFK 0.98–1.18 7.8 1.14–1.50 11.0
SWNAHFTEHK 5.95–7.29 7.4 6.89–9.91 14.0
NDM FGDLVFR 0.83–2.23 51.1 0.98–4.59 57.3
QEINLPVALAVVTHAHQDK ∗ ∗ ∗ ∗
VIM VGGVDVLR 14.35–18.35 9.5 14.70–18.76 9.3
NTAALLAEIEK 0.43–0.63 14.4 0.38–0.48 12.0
Each strain was processed in fivefold. Ratios were calculated by dividing peak areas of endogenous peptides to stable isotope-labeled peptides. CV’s were calculated of
these ratios. ∗QEINLPVALAVVTHAHQDK was not detected in both samples.
TABLE 3 | Sensitivity and specificity of LC-MS/MS compared to PCR in 83 strains.
Carbapenemase Target peptide Sensitivity %, CI %, (n MS
positive/n PCR positive)
Specificity %, CI %, (n MS
negative/n PCR negative)
KPC SIGDTTFR 100, 76–100 (16/16) 100, 93–100 (67/67)
FPLCSSFK 100, 76–100 (16/16) 100, 93–100 (67/67)
One or both KPC peptides positive 100 (16/16) 100 (67/67)
OXA-48-like ANQAFLPASTFK 100, 81–100 (21/21) 100, 93–100 (62/62)
SWNAHFTEHK 100, 81–100 (21/21) 100, 93–100 (62/62)
One or both OXA-48-like peptides positive 100 (21/21) 100 (62/62)
NDM FGDLVFR 100, 76–100 (16/16) 100, 93–100 (67/67)
QEINLPVALAVVTHAHQDK 25, 8–53 (4/16) 100, 93–100 (67/67)
One or both NDM peptides positive 100 (16/16) 100 (67/67)
VIM VGGVDVLR 100, 72–100 (13/13) 100, 94–100 (70/70)
NTAALLAEIEK 92, 62–100 (12/13) 100, 94–100 (70/70)
One or both VIM peptides positive 100 (13/13) 100 (13/13)
overnight digestion. These results demonstrate that shorter
trypsin incubation times are feasible without compromising
the sensitivity of the assay provided to include only the best
performing peptides.
DISCUSSION
In an era of increasing antimicrobial resistance new technologies
are needed to facilitate early optimal antibiotic therapy and timely
infection prevention measures (van Belkum and Dunne, 2013;
Perez et al., 2014; WHO, 2014; The Review on Antimicrobial
Resistance, 2016; Tacconelli et al., 2018). PCR and WGS are
frequently used as confirmation techniques or even cited as
techniques replacing conventional AST. However, PCR is limited
in multiplexing capacity and WGS is at present still expensive
and not yet suited to be a routine method for the most
frequently isolated pathogens (Ellington et al., 2017). Lateral flow
immunoassays are an alternative to PCR and can be used for
rapid detection of some resistance mechanisms (Boutal et al.,
2018; Volland et al., 2019).
A technique able to detect most prevalent resistance
mechanisms simultaneously, accurately and rapidly would be
beneficial to prevent further spread of AMR and initiate
optimal therapy in an early stage of infection. Although targeted
LC-MS/MS is not routinely used for detection of resistance
mechanisms, it does offer some advantages. It is less hampered by
multiplexing issues than PCR and immunoassays. Furthermore,
results can be obtained rapidly when sample pre-treatment
time and organism enrichment can be by-passed or shortened
(Charretier et al., 2015; Wang et al., 2017; Saleh et al., 2019;
Strich et al., 2019).
To further explore the possibilities of high resolution
mass spectrometry in detecting resistance mechanisms, a mass
spectrometry workflow was developed and tested for detection of
the most prevalent carbapenemases in a single analysis. As proof
of principle, 83 isolates consisting of E. coli and K. pneumoniae
were tested for the presence of KPC, OXA-48-like, NDM and
VIM enzymes. All present carbapenemases were detected, either
by detecting one of the two selected target peptides or both, which
was the case for the majority of isolates.
In contrast to other studies that demonstrated direct
detection of KPC, OXA-48-like and NDM carbapenemases using
targeted LC-MS/MS we broadened the detectable spectrum
by VIM (Wang et al., 2017; Cecchini et al., 2018; Strich
et al., 2019). Furthermore, it was demonstrated that it is
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FIGURE 3 | Validation of the LC-MS/MS technique in 83 isolates. Intensity ratios of selected KPC, VIM, OXA-48-like and NDM endogenous target peptides to spiked
stable isotope-labeled reference peptides (logarithmic scale) are plotted for each isolate. PCR positive isolates are grouped together in the figure and marked by a
line for each respective carbapenemase. The bottom graph shows intensity of the ribosomal protein which was selected as internal control in unadjusted units (108).
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technically feasible to measure four carbapenemases in a
single assay with 100% sensitivity and specificity. This was
in part possible due to the use of PRM instead of SRM.
The first shown in a recent study, to have a lower limit of
detection and better overall performance in complex samples
(Guzel et al., 2018).
In the current assay, 9 endogenous and 8 SIL peptides were
measured in a single analysis. It is however, technically feasible
to detect many more different peptides at the same time. In a
study of Charretier et al. (2015), 109 endogenous Staphylococcus
aureus and 49 synthesized peptides were measured in a single
experiment by SRM although this did extend the LC gradient and
MS analysis to 34 min for each sample.
In addition to carbapenemases, other resistance mechanisms
of Enterobacterales have been detected by LC-MS such as
the ESBL CTX-M by Fleurbaaij et al. (2017). But also the
detection of different amino-acid substitutions in the GyrA
protein resulting in quinolone resistance of Salmonella enterica
isolates was demonstrated in a paper of Hassing et al. (2016).
These studies indicate that LC-MS is universally applicable
for protein detection of different resistance mechanisms. By
expanding the current detection of carbapenemases by ESBL’s,
mutated gyrases, aminoglycoside modifying enzymes and even
absence of porins, a single MS assay has the potential to
detect many different resistance mechanisms simultaneously.
Hypothetically, even the combined presence of two resistance
mechanisms affecting the same antibiotic could be detected.
For example, a lack of porins combined with beta-lactamase
production leading to reduced susceptibility to carbapenems
(Goessens et al., 2013).
To achieve a high sensitivity in detecting different resistance
mechanisms, it is important to take different subtypes into
account. In the current selection process, all subtypes of
each carbapenemase gene were taken into consideration. This
resulted in a high coverage of each carbapenemase. To
illustrate: all new CPE isolates recovered from patients in
the Netherlands are characterized by the National Institute
for Public Health and Environment. In 2017, 235 new CPE
isolates were submitted of which 220 (93.6%) had a known
subtype (Mouton and de Greeff, 2018). All of these subtypes
were covered by our selected peptides except for one OXA-
23 (which is obvious as it is not part of the OXA-48 family)
(Mairi et al., 2018).
In addition to being sensitive, peptides should also be
specific. In this study specificity was assessed in vitro
and by BLASTp searches for the target peptides. All
carbapenemase peptides were specific for their respective
resistance mechanisms in Enterobacterales except for the
two KPC peptides. Although FPLCSSFK aligned with
multiple other class A carbapenemases, SIGDTTFR was
only present in KPC and the class A carbapenemase
SED produced by Citrobacter species. Furthermore, it
should be noted that although the peptides selected for
“OXA-48-like” are specific for the OXA-48 family, the
enzymes OXA-163, OXA-247, and OXA-405 within this
family will be detected but do not hydrolyze carbapenems
(Strich et al., 2019).
In addition to the specific carbapenemase peptides, a 30 S
ribosomal protein was added to the assay as an internal control
for which 82/83 strains tested positive. Because a negative
result was remarkable for such an abundant protein, WGS
was performed on the internal control negative isolate. This
demonstrated a mutation in the target gene which led to
the peptide sequence HEAWISLEK instead of HEAWITLEK,
explaining why this strain tested negative.
The present results are encouraging, especially when reducing
the turnaround time, making the technique more suitable
for routine diagnostics. The pre-treatment protocol currently
used was not yet optimized to be as short and simple as
possible. However, in a pilot it was demonstrated that all four
carbapenemases can be detected within a few hours using shorter
digestion times. In a study by Wang et al. (2017), total time
from culture to results was reduced to 90 min for detection
of KPC using a relatively simple pre-treatment protocol. The
currently used pre-treatment protocol and the protocol used
by Wang et al. (2017) are both relatively easy to automate
which would further decrease turnaround time and increase
applicability (Sabbagh et al., 2016).
Besides turnaround time, it is also important to decrease
hands-on time per sample, as most laboratories analyze high
numbers of isolates making automation of this technique a
requisite. In the present study, the Evosep One was used
as an integrated liquid chromatograph and auto-sampler
which reduced turnaround time. The system had two other
benefits. First, no carryover was detected making blank runs
redundant. Second, high sample throughput was demonstrated
using an 11.5 min elution gradient, potentially analyzing
100 samples a day.
Although the present study was “proof of concept,” the
results show the potential of targeted high resolution MS in
detecting different resistance mechanisms. If the target panel
would be expanded by peptides specific for aminoglycoside
modifying enzymes, gyrase mutations, penicillinases (such
as SHV and TEM), and ESBLs (such as CTX-M), rapid
screening of for instance positive blood cultures could be
beneficial, provided that high-resolution MS is available in
a routine setting. By using the bacteria present in positive
blood cultures, subsequent processing and analysis by targeted
MS could result in early information on the presence of
these resistance mechanisms. This could in turn facilitate
an earlier switch to the most appropriate therapy. However,
before considering application in a routine setting further
validation using more strains with different resistance
mechanisms is warranted.
In summary, a bottom up LC-MS/MS method was developed
which could accurately detect KPC, OXA-48-like, NDM and VIM
carbapenemases and which has the potential to rapidly detect
many other resistance mechanisms in a single assay as well.
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